• 1. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 2. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 3. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 4. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 5. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977

Methyl 3-amino-2-hydroxy-5-methoxybenzenecarboxylate (CAS No. 55008-18-9): A Comprehensive Overview

Methyl 3-amino-2-hydroxy-5-methoxybenzenecarboxylate, identified by its CAS number 55008-18-9, is a compound of significant interest in the field of pharmaceutical chemistry and biochemistry. This compound, belonging to the class of phenolic derivatives, has garnered attention due to its potential biological activities and structural properties that make it a valuable intermediate in the synthesis of various pharmacologically active molecules.

The molecular structure of Methyl 3-amino-2-hydroxy-5-methoxybenzenecarboxylate consists of a benzene ring substituted with an amino group at the 3-position, a hydroxyl group at the 2-position, and a methoxy group at the 5-position. This arrangement of functional groups imparts unique chemical and biological properties to the compound, making it a versatile building block for drug discovery and development.

In recent years, there has been a growing interest in exploring the pharmacological potential of phenolic compounds, particularly those with multiple substituents that can interact with biological targets in complex ways. The presence of both amino and hydroxyl groups in Methyl 3-amino-2-hydroxy-5-methoxybenzenecarboxylate suggests that it may exhibit a range of biological activities, including antioxidant, anti-inflammatory, and antimicrobial properties. These properties have been extensively studied in various preclinical models, providing a strong foundation for further investigation into its therapeutic applications.

One of the most compelling aspects of Methyl 3-amino-2-hydroxy-5-methoxybenzenecarboxylate is its role as a key intermediate in the synthesis of more complex molecules. Its structural features allow for facile modifications at multiple positions on the benzene ring, enabling the creation of derivatives with tailored biological activities. For instance, researchers have utilized this compound to develop novel inhibitors targeting specific enzymes involved in metabolic pathways relevant to diseases such as diabetes and cancer.

The synthesis of Methyl 3-amino-2-hydroxy-5-methoxybenzenecarboxylate typically involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include nucleophilic aromatic substitution reactions, reduction processes, and etherification steps. Advanced techniques such as catalytic hydrogenation and palladium-catalyzed cross-coupling reactions have also been employed to enhance the efficiency of the synthesis process.

The pharmacological evaluation of Methyl 3-amino-2-hydroxy-5-methoxybenzenecarboxylate has revealed several promising activities. In vitro studies have demonstrated its ability to inhibit the growth of various cancer cell lines by inducing apoptosis and disrupting cell cycle progression. Additionally, preliminary in vivo studies suggest that this compound may possess anti-inflammatory effects by modulating key signaling pathways involved in immune responses.

The potential therapeutic applications of Methyl 3-amino-2-hydroxy-5-methoxybenzenecarboxylate are vast and varied. Given its structural similarity to known pharmacophores, it is likely to be explored as a lead compound for the development of new drugs targeting a wide range of diseases. Furthermore, its role as a versatile intermediate makes it an attractive candidate for combinatorial chemistry approaches aimed at identifying novel drug candidates with improved efficacy and reduced toxicity.

Recent advancements in computational chemistry have also contributed to the understanding of the biological activity of Methyl 3-amino-2-hydroxy-5-methoxybenzenecarboxylate. Molecular docking studies have been used to predict how this compound interacts with target proteins, providing insights into its mechanism of action. These computational approaches have complemented traditional experimental methods, enabling researchers to design more effective derivatives with enhanced binding affinity and selectivity.

The future prospects for Methyl 3-amino-2-hydroxy-5-methoxybenzenecarboxylate are bright, with ongoing research aimed at elucidating its full pharmacological profile and optimizing its synthetic pathways. As our understanding of its biological activities grows, so too does its potential as a therapeutic agent. The compound's unique structural features make it an invaluable tool for drug discovery efforts across multiple therapeutic areas.

• 61203-57-4(Benzoic acid, 4-amino-2,3-dimethoxy-, methyl ester)
• 591206-11-0(2H-1,5-Benzodioxepin-6-carboxylic acid, 9-amino-3,4-dihydro-, methyl ester)
• 35748-34-6(3-Amino-2-hydroxybenzoic Acid Methyl Ester)
• 70752-22-6(methyl 5-amino-2,4-dimethoxybenzoate)
• 182067-64-7(Benzoic acid,4-amino-2-ethoxy-3-hydroxy-, methyl ester)
• 201287-71-0(Benzoic acid,3-amino-2-hydroxy-4-methoxy-, methyl ester)
• 22802-67-1(Methyl 5-Amino-2-methoxybenzoate)
• 538372-37-1(Methyl 3,4-diamino-2-methoxybenzoate)
• 5129-25-9(Methyl 3-amino-2-methoxybenzoate)
• 591206-84-7(2H-1,5-Benzodioxepin-6-carboxylic acid, 8-amino-3,4-dihydro-, methylester)